InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Explore the full record of transactions filed by Decker Lisa Lynn, Directeur Commercial. Director active across 1 company, notably IGM Biosciences, Inc.. In total, 8 reports have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €22k. History available since 15 November 2021. The latest transaction was disclosed on 24 May 2022 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations8 total
1,362 shares@ US$17.102336.6% of flowCommon StockSEC:0001209191-22-032224:0
413 shares@ US$12.388.3% of flowCommon StockSEC:0001209191-22-029854:0
4,617 shares0Common StockSEC:0001209191-22-019752:0
7,500 shares0Common StockSEC:0001209191-22-019008:0
10,000 shares0Common StockSEC:0001209191-21-065980:0
10,000 shares0Common StockSEC:0001209191-21-065980
367 shares@ US$50.99100.0% of flowCommon StockSEC:0001209191-21-065253
367 shares@ US$50.9927.6% of flowCommon StockSEC:0001209191-21-065253:0
8 of 8 declarations
About Decker Lisa Lynn
Lisa Lynn Decker is the Chief Business Officer at IGM Biosciences, Inc. She is responsible for the company's business strategy, overseeing business development and growth initiatives.
